Aclacinomycin A hydrochloride

Aclacinomycin A hydrochloride is an inhibitor of Topoisomerase and E3 Ligase used in studies of DNA Damage Response and Protein Degradation / Proteasome. In practice, this places the compound in experiments that measure checkpoint activation, DNA repair, and genome-stability control and ubiquitin-dependent turnover, proteostasis, and targeted protein degradation in cancer, cell cycle, and dna damage / repair models.

By inhibiting Topoisomerase and E3 Ligase, Aclacinomycin A hydrochloride can be used to examine checkpoint activation, DNA repair, and genome-stability control and ubiquitin-dependent turnover, proteostasis, and targeted protein degradation. The enzyme annotation adds relevance to enzyme-activity assays, substrate-conversion studies, and mechanism profiling, together with downstream-response mapping in the same experimental setting. In cancer, cell cycle, and dna damage / repair models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Topoisomerase and E3 Ligase
• Pathway perturbation studies connected to DNA Damage Response and Protein Degradation / Proteasome
• Concentration-response inhibition and target-dependence studies
• Enzyme-activity assays, substrate-conversion studies, and mechanism profiling

Overall, Aclacinomycin A hydrochloride is appropriate when a defined chemical perturbant is needed to connect Topoisomerase and E3 Ligase with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell cycle, and dna damage / repair models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.